Navigation Links
Watson Announces Limited Recall Of Fentanyl Transdermal System
Date:8/7/2009

>

Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch Web site at www.fda.gov/medwatch.

Watson's Fentanyl Transdermal System CII is indicated for the management of persistent, moderate to severe chronic pain that requires continuous, around the clock opioid administration for an extended period of time and cannot be managed by other means such as non-steroidal analgesics, opioid combination products, or immediate release opioids.

Anyone who comes in contact with fentanyl gel should thoroughly rinse exposed skin with large amounts of water only; do not use soap. Immediately dispose of affected patches that may be damaged or compromised in any way by flushing them down the toilet, using caution not to handle them directly. Damaged and/or compromised patches that have leaked gel will not provide effective pain relief.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release.
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
2. Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
3. Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
4. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
5. Watson CFO Mark W. Durand to Take Leave of Absence
6. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
7. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
8. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
9. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
10. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
11. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (PRWEB) May 17, 2013 Fighting addiction ... complications, but for diabetics, treatment is more difficult and ... medical care to monitor blood sugar levels and administer ... properly, a drug rehab for diabetics needs ... and nutritional needs of the diabetic, and has experience ...
(Date:5/17/2013)... "screen time" and sleep on mood, memory and ... at the 2013 Intel International Science and Engineering ... school students. The awards are coordinated by the ... the National Institutes of Health, and Friends of ... Intel ISEF Addiction Science Awards were presented at ...
(Date:5/17/2013)... Too few obstetrics-gynecology residents in the United States receive ... issues for the rapidly growing number of older American ... ob/gyn residents and found that fewer than one in ... though seven in 10 would like to receive it. ... -- those soon to complete their training -- said ...
(Date:5/17/2013)... (SACRAMENTO, Calif.) Working with lab mice models of ... novel molecular target for the design of drugs that ... medications against MS. , The findings of the ... EMBO Molecular Medicine could have therapeutic applications for ... disorders associated with loss of white matter, which is ...
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 The ... news on the site for women using the vaginal ... panel shows the number of claims alleging blood clots ... was created to improve the safety of patients using ... research and legal news. Visitors can find out if ...
Breaking Medicine News(10 mins):Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4Health News:Is Menopause Overlooked in U.S. Medical Schools? 2Health News:Study identifies new approach to improving treatment for MS and other conditions 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
... Four days after an Indian pilgrim died of respiratory ... the Indo-China border, another Indian woman too succumbed// to ... that one of the holiest pilgrim sites in Asia ... Indian travellers. ,Meenakshi Devi Shriram Bhoyar, a ...
... the Intellectual Property law raised a lot of oppositions from ... mainly aim to restrict the government from buying the cheap ... tuberculosis. Officials point out to the fact that these changes ... are cheaper. The NGOs are also against an amendment as ...
... agreed to provide a grant assistance of Rs.190 million ... (IIPI) campaign// in India this year, parliament was informed ... Welfare Minister Anbumani Ramadoss told the Lok Sabha: 'The ... UNICEF to be used during the pulse polio rounds ...
... a therapy that eases iron overload, according to researchers. ... the current issue of Human Reproduction. ,Women ... which attaches to ligaments and organs in the abdomen. ... infertility and adhesions. About 10 percent of women may ...
... Uttar Pradesh government has asked medical officials in the district ... villages of Loni and Bhojpur blocks// where two suspected cases ... directives were issued by the UP Health Secretary and the ... about it, District Magistrate M K S Sundaram said today., ...
... Women in the age of 40 to 50 years are ... play a vital role in the disease because of the ... A new study has examined the role played by estradiol, ... women and how it works in the development of osteoarthritis. ...
Cached Medicine News:Health News:High-altitude Illness Affects Pilgrims of Mansarovar 2Health News:Knee Osteoarthritis May Be Triggered By Low Levels Of Estrogen 2
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of Malarial antigen in Human whole blood....
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
Medicine Products: